[en] Background/Aim: Human papillomavirus (HPV) is implicated in head and neck squamous cell carcinomas. However, the causal role of HPV in carcinomas of the parotid gland remains uncertain and less documented. This study aimed to determine the potential implication of HPV in the development of benign and malignant lesions of the parotid gland. MATERIALS AND METHODS: Paraffin-embedded biopsies were obtained from 40 patients with benign parotid gland tumors and from 39 patients with parotid gland carcinomas. The 79 samples were evaluated for the presence of HPV DNA using both GP5+/GP6+ consensus Polymerase Chain Reaction (PCR) and type-specific E6/E7 PCR to detect 18 HPV types. RESULTS: Our results showed a low prevalence of HPV, with only three HPV-positive cases among the 40 benign tumors and one infected carcinoma in the malignant population. CONCLUSION: No association between the presence of HPV DNA and the development of parotid gland tumors was found in our study.
Disciplines :
Oncology
Author, co-author :
Descamps, Geraldine
Duray, Anaelle
Rodriguez, Alexandra
Chantrain, Gilbert
Depuydt, Christophe E.
DELVENNE, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
Saussez, Sven
Language :
English
Title :
Detection and quantification of human papillomavirus in benign and malignant parotid lesions.
Publication date :
2012
Journal title :
Anticancer Research
ISSN :
0250-7005
eISSN :
1791-7530
Publisher :
International Institute of Anticancer Research, Greece
Syrjänen K, Syrjänen S, Lamberg M, Pyrhonen S and Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Maxillofac Surg 12: 418-424, 1983.
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH and Gillison ML: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956, 2007.
Vageli D, Sourvinos G, Ioannou M, Koukoulis GK and Spandidos DA: High-risk human papillomavirus (HPV) in parotid lesions. Int J Biol Markers 22: 239-244, 2007.
Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, Sasaki C, Joe J, Camp RL, Rimm DL and Psyrri A: Molecular classification identifies a subset of human papillomavirus associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24: 736-747, 2006.
Duray A, Descamps G, Arafa M, Decaestecker C, Remmelink M, Sirtaine N, Ernoux-Neufcoeur P, Mutijima E, Somja J, Depuydt CE, Delvenne P and Saussez S: High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol 39: 51-59, 2011.
Duray A, Descamps G, Decaestecker C, Remmelink M, Sirtaine N, Lechien J, Ernoux-Neufcoeur P, Bletard N, Somja J, Depuydt CE, Delvenne P and Saussez S: Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 122: 1558-1565, 2012.
Smith EM, Rubenstein LM, Hoffman H, Haugen TH and Turek LP. Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer. Infect Agent Cancer 5: 4, 2010.
Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Bartek J and Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633, 1996.
Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F and Tannapfel A. Alterations of the INK4A-ARF gene locus in pleomorphic adenoma of the parotid gland. J Pathol 198: 326-334, 2002.
Ernoux-Neufcoeur P, Arafa M, Decaestecker C, Duray A, Remmelink M, Leroy X, Herfs M, Somja J, Depuydt CE, Delvenne P and Saussez S: Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol 137: 173-181, 2011.
Depuydt CE, Boulet GA, Horvath CA, Benoy IH, Vereecken AJ and Bogers JJ: Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med 11: 881-91, 2007.
Gnanamony M, Peedicayil A, Subhashini J, Ram TS, Rajasekar A, Gravitt P and Abraham P: Detection and quantitation of HPV 16 and 18 in plasma of Indian women with cervical cancer. Gynecol Oncol 116: 447-51, 2010.
Petersen I and Klein F: HPV in non-gynecological tumors. Pathologe 29: 118-122, 2008.
Hennig EM, Suo Z, Thoresen S, Holm R, Kvinnsland S and Nesland JM: Human papillomavirus 16 in breast cancer of women treated for high-grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat 53: 121-135, 1999.
Tseng CJ, Pao CC, Lin JD, Soong YK, Hong JH and Hsueh S: Detection of human papillomavirus types 16 and 18 mRNA in peripheral blood of advanced cervical cancer patients and its association with prognosis. J Clin Oncol 17: 1391-1396, 1999.
